世界杯官方app to Establish Preclinical Pharmacology Core and Young Investigator Awards with $1.沃尔克基金捐赠的700万美元
The trustees of the Max and Minnie Tomerlin Voelcker Fund have awarded the College of Sciences and chemistry professor Doug 弗朗茨 $883,000 to establish the Max and Minnie Tomerlin Voelcker CIDD Preclinical Pharmacology Core for Accelerated Drug Discovery. 该核心将成为世界杯官方app创新药物发现中心的一部分. 由导演斯坦顿·麦克哈迪领导, the CIDD catalyzes collaborations with investigators by providing services and expertise related to small-molecule drug discovery and preclinical drug development. 另一个900美元,000 will support the Max and Minnie Tomerlin Voelcker Young Investigator Awards, 谁能帮助两位冉冉升起的超级明星教员.
Researchers in the core will work with the CIDD’s High-Throughput Screening Core Facility and the Max and Minnie Tomerlin Voelcker Medicinal Chemistry Core Facility. They will also collaborate with 世界杯官方app’s Stem Core Facility to develop innovative technologies that determine the cardiovascular safety of all new drugs under development.
Preclinical pharmacology is a critical piece of the drug discovery pipeline. It allows researchers to optimize potential new drugs by studying various aspects of toxicology, 包括吸收, 分布, 代谢与排泄. Each of these is needed to file an Investigational New Drug application to the federal Food and Drug Administration.
“The [pharmacology core] will provide the missing link in San Antonio’s drug-discovery ecosystem.”
以前, CIDD不得不外包所有的临床前药理工作, 这导致了巨大的成本和漫长的延误. The Voelcker Fund’s award will allow researchers to save valuable time and resources.
沃尔克基金支持寻找医学疾病治疗方法的研究. “中国国际发展研究院的医学研究能力是无限的,班克斯·史密斯说, 沃尔克基金的受托人. “它的工作加速了疾病治疗方法的发现.”
Researchers in the CIDD will utilize the core’s cutting-edge late-stage preclinical pharmacology and translational drug development capabilities to launch new therapies in a broad range of indications, 包括癌症, 心血管病, 神经退化, 慢性疼痛和传染性疾病.
The addition of the core provides a unique suite of industry-level services to South Texas biomedical researchers. 弗朗茨 believes that the core will help establish new collaborative opportunities between 世界杯官方app, UT健康圣安东尼奥, 德克萨斯生物医学研究所和西南研究所.
“The Max and Minnie Tomerlin Voelcker CIDD Preclinical Pharmacology Core for Accelerated Drug Discovery will provide the missing link in San Antonio’s drug-discovery ecosystem and allow local researchers to rapidly identify the best drug leads to move forward into the clinic,弗朗茨说.
了解更多世界杯官方app世界杯官方app创新药物发现中心的信息.
A portion of the funds will also support the CIDD Undergraduate Summer Internship, which offers a research-focused laboratory experience for undergraduate students. Student support accelerates research in fields such as cancer and heart disease.
"在这个新的暑期实习机会下, selected undergraduate students in the College of Sciences will undergo an intensive 10-week hands-on laboratory experience to train them in the skills and techniques required for a successful career in the pharmaceutical industry,弗朗茨说.
弗朗茨, who holds the Max and Minnie Tomerlin Voelcker Distinguished Professorship in Chemistry, 2012年共同创立了CIDD. 从那时起, the center has participated in over 50 novel drug-discovery programs across a range of therapeutic areas, 已经发表了超过25篇同行评议的论文, over 15 invention disclosures and more than $17 million in extramural funding.
-劳伦·莫里亚蒂
